ENGLISH 日本语
Home > Firm News> 2018 > Gaopeng & Partners Hangzhou Office Assists Hangzhou Huafang Chuangliang Investment Management Co., Ltd. to Complete the Major Changes of Private Equity Fund Manager

Gaopeng & Partners Hangzhou Office Assists Hangzhou Huafang Chuangliang Investment Management Co., Ltd. to Complete the Major Changes of Private Equity Fund Manager

2018-2-6

    Recently, Gaopeng & Partners Hangzhou Office provided special legal service for handling the major changes of legal representative of private equity fund manager with the Asset Management Association of China (AMAC) under the entrustment of Hangzhou Huafang Chuangliang Investment Management Co., Ltd. and the changes have successfully passed the review of the AMAC. Our senior partners, including Lawyer Qian Yuxin, Lawyer Chen Jianchun and Lawyer Mao Zhiying, provided legal services for the major changes of private equity fund manager throughout the process. 

    Established in August 2016, Hangzhou Huafang Chuangliang Investment Management Co., Ltd. is a wholly-owned sub-subsidiary of Holley Pharmaceutical Group Co., Ltd.. With rich experience in investment projects both at home and abroad, its fund investment team is familiar with medial industry at home and broad as well as the operation rules and the development trend of the capital market, and have already initiated the establishment of several private equity funds. 



Copyright 2006-2012 www.gaopenglaw.com All Rights Reserved.
Gaopeng & Partners
ICP:京公网安备11010502023747